Theralase Technologies Inc. V.TLT

Can you imagine

[blackjack0]

I have always wondered what if TLD1433 was an option for treatment of a first diagnosis of bladder cancer! What would the numbers look like then . Like what would the complete response, partial response etc. be then we could truly be comparing our treatment to the competition . Nothing close imo

[Legit62]

Great point, why wait to use it as last response treatment  and put patients through all the other treatments first, maybe some day that will be the case when a big pharma with the money owns us

[Eoganacht]

I think what happens is, when you have a new treatment which is for a very time sensitive disease you go to the back of the line. It is very important that high-risk NMIBC is treated effectively before it advances to MBIC. Half of all patients with non-metastatic MIBC will not survive 5 years.The most effective treatment seems to be radical cystectomy (5 year survival rate of 54% - 68%) but if you

[99942Apophis]

Well stated Eoganacht and that might be in my opinion one of the reasons why pre-BTD is taking a little  longer as you've pointed out that somewhere down the line Ruvidar could be a candidate for SOC.  We don't know long term affects it could cause and perhaps FDA has strongly considered Ruvidar as the future SOC treatment so a little longer scrutiny might be required for the

[Johnandrose22]

I am, indeed, confused, Sir....Your previous responses to my discussion board inquiries made clear that, in the end, despite my enthusiasm for the companies remarkable clinical data it is down to financial viability...ie...will the company financially survive and will the market factor this in...To be candid, this recent "survey" by the company send chills down my spine regarding your